Role of the Intestinal Microbiome in Cholestatic Liver Disease.

LaRusso NF, Tabibian JH, O’Hara SP et al.

Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minn., USA.

Digestive diseases (Basel, Switzerland). 2017.

Hepatobiliary health and disease is influenced by multiple factors including genetics, epigenetics, and the environment. Recently, multiple lines of evidence suggest that the microbiome also plays a central role in the initiation and/or progression of several liver diseases. Our current understanding of the dynamic interplay between microbes, microbial products and liver health and pathophysiology is incomplete. However, exciting insights are continually being made that support both a central role of the microbiome and a need for further interrogation of the microbes or microbe-associated molecules involved in the initiation and progression of select liver diseases.


Leave a Reply

Your email address will not be published. Required fields are marked *